Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5630199 | Journal of Neuroimmunology | 2017 | 9 Pages |
â¢Higher sera levels of BMP-2 in patients with RR-MSâ¢BMP-2 levels correlated with BMP-4 and -5 levels only in sera of untreated MS patients.â¢Sera of untreated patients inhibited the neuronal differentiation of RA-treated P19 cells.â¢Sera of untreated patients induced high phospho-SMAD.â¢A pro-neurogenic mechanism of action of IFN-β therapy.
Blockage of bone morphogenetic protein (BMP) signaling is required for differentiation of neurons and oligodendrocytes from neural stem cells (NSCs). Sera of untreated relapsing-remitting multiple sclerosis (RR-MS) patients expressed significantly higher levels of BMP-2 compared to sera of healthy controls. BMP-2 levels correlated with BMP-4 and -5 levels only in sera of untreated MS patients. Furthermore, sera of untreated patients inhibited the neuronal differentiation of RA-treated P19 cells, which was associated with induction of phospho-SMAD signaling pathway. These results suggest that BMP-2 sera levels may play a role in the failure of remyelination and neuro-regeneration in RR-MS.
Graphical abstractHigh sera levels of BMP-2 in untreated patients with RR-MS.Download high-res image (65KB)Download full-size image